End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
92.2 BDT | +0.22% | -8.89% | +9.24% |
Quotes 5-day view
End-of-day quote Dhaka S.E.26/05/2024 | 27/05/2024 | 28/05/2024 | 29/05/2024 | 30/05/2024 | |
---|---|---|---|---|---|
Last | 98.2 BDT | 97.7 BDT | 94.8 BDT | 92 BDT | 92.2 BDT |
Volume | 106 560 | 910 272 | 617 028 | 237 739 | 299 290 |
Change | -2.96% | -0.51% | -2.97% | -2.95% | +0.22% |
Opening | 98.20 | 95.50 | 99.50 | 92.20 | 89.50 |
High | 98.20 | 98.90 | 100.80 | 93.50 | 93.20 |
Low | 98.20 | 95.30 | 94.80 | 92.00 | 89.30 |
Performance
1 day | +0.22% | ||
1 week | -8.89% | ||
Current month | +7.46% | ||
1 month | +7.46% | ||
3 months | -0.43% | ||
6 months | +8.85% | ||
Current year | +9.24% | ||
1 year | -14.07% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+0.22% | -8.89% | +9.24% | -14.07% | 84.35M | ||
+0.65% | +1.47% | +40.73% | +92.01% | 734B | ||
+1.13% | -1.08% | +32.83% | +66.18% | 591B | ||
+1.09% | -1.90% | -6.30% | -4.86% | 350B | ||
+0.81% | -4.23% | +15.15% | +14.99% | 315B | ||
+3.15% | +1.88% | +4.05% | +18.18% | 276B | ||
+1.35% | -1.73% | +15.00% | +6.02% | 238B | ||
+2.13% | +0.43% | +9.78% | +7.07% | 206B | ||
+1.18% | -0.47% | -5.52% | -19.76% | 204B | ||
+1.59% | -0.23% | +6.17% | +39.94% | 161B | ||
+1.63% | -0.10% | -0.45% | -22.56% | 160B | ||
+1.34% | -0.44% | -.--% | -4.82% | 120B | ||
+2.11% | -0.65% | +21.81% | +28.85% | 89.9B | ||
+2.17% | -1.00% | -19.85% | -35.45% | 81.59B | ||
+0.28% | -2.89% | -20.68% | -15.81% | 79.83B | ||
+3.32% | +3.74% | +44.06% | +22.06% | 66.06B | ||
Average | +1.36% | -2.30% | +9.13% | +11.12% | ||
Weighted average by Cap. | +1.23% | -1.78% | +16.33% | +31.51% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +9.24% | ||
2023 | +7.79% | ||
2022 | +196.59% |
- Stock Market
- Equities
- NAVANAPHAR Stock
- Quotes Navana Pharmaceuticals PLC